What Is the Generic Equivalent of Lantus?
-
Identification
-
Lantus is a synthetic insulin analog rather than actual insulin. It is made through recombinant DNA technology (rDNA) of a non-pathogenic type of bacteria.
Patents
-
A medication can only be sold in a generic version after the original manufacturer's patents expire. The first Lantus patent is set to expire in May 2010, but the company holds additional patents that expire at a later date.
Drug Type
-
Because Lantus is developed from a living organism, it is classified as a biologic.
Regulations
-
As of 2010, U.S. regulations do not allow manufacturers to make generic biologic drugs. This prevents Lantus from being offered in a generic equivalent for the foreseeable future.
Other Biologics
-
Examples of other biologics include vaccines and certain drugs for rheumatoid arthritis and psoriasis.
-